PuraPharm Corp. Ltd. (1498) Ratios

0 Followers

PuraPharm Corp. Ltd. Ratios

HK:1498's free cash flow for Q2 2025 was HK$0.55. For the 2025 fiscal year, HK:1498's free cash flow was decreased by HK$ and operating cash flow was HK$-0.09. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	0.47	0.55	0.61	0.73	0.92
Quick Ratio	0.27	0.30	0.30	0.44	0.62
Cash Ratio	0.04	0.03	0.04	0.16	0.09
Solvency Ratio	<0.01	<0.01	-0.08	-0.09	-0.09
Operating Cash Flow Ratio	0.19	0.21	0.14	0.10	-0.06
Short-Term Operating Cash Flow Coverage	0.33	0.42	0.26	0.16	-0.10
Net Current Asset Value	HK$ -333.50M	HK$ -336.09M	HK$ -341.16M	HK$ -271.19M	HK$ -192.27M
Leverage Ratios
Debt-to-Assets Ratio	0.51	0.51	0.50	0.49	0.44
Debt-to-Equity Ratio	2.69	3.27	2.77	1.95	1.32
Debt-to-Capital Ratio	0.73	0.77	0.73	0.66	0.57
Long-Term Debt-to-Capital Ratio	0.30	0.45	0.35	0.16	0.19
Financial Leverage Ratio	5.32	6.44	5.51	3.94	3.00
Debt Service Coverage Ratio	0.06	0.04	-0.09	-0.11	-0.10
Interest Coverage Ratio	-1.10	-1.24	-1.88	-2.67	0.65
Debt to Market Cap	2.58	1.56	1.10	0.91	1.57
Interest Debt Per Share	0.80	0.98	1.14	1.34	1.42
Net Debt to EBITDA	16.11	20.23	-15.38	-8.55	-11.80
Profitability Margins
Gross Profit Margin	53.46%	53.69%	53.24%	58.16%	63.96%
EBIT Margin	-5.13%	-4.78%	-18.41%	-21.20%	-13.67%
EBITDA Margin	6.09%	4.54%	-6.47%	-10.34%	-6.07%
Operating Profit Margin	-6.77%	-7.70%	-12.68%	-14.40%	2.67%
Pretax Profit Margin	-10.24%	-7.55%	-25.15%	-26.60%	-17.77%
Net Profit Margin	-10.48%	-9.28%	-26.07%	-26.83%	-18.48%
Continuous Operations Profit Margin	-10.48%	-9.28%	-26.07%	-26.83%	-18.48%
Net Income Per EBT	102.36%	122.92%	103.68%	100.87%	104.00%
EBT Per EBIT	151.13%	98.02%	198.34%	184.78%	-665.18%
Return on Assets (ROA)	-5.08%	-4.95%	-12.57%	-11.83%	-10.11%
Return on Equity (ROE)	-30.35%	-31.87%	-69.23%	-46.54%	-30.35%
Return on Capital Employed (ROCE)	-10.62%	-13.09%	-18.90%	-18.37%	3.26%
Return on Invested Capital (ROIC)	-4.57%	-6.02%	-8.67%	-8.27%	1.83%
Return on Tangible Assets	-5.79%	-5.32%	-13.41%	-12.83%	-10.85%
Earnings Yield	-24.09%	-16.31%	-30.17%	-23.80%	-38.22%
Efficiency Ratios
Receivables Turnover	5.96	6.65	3.60	3.40	2.20
Payables Turnover	1.84	1.34	1.30	1.36	1.69
Inventory Turnover	1.58	1.43	1.08	0.98	1.19
Fixed Asset Turnover	0.95	1.08	1.03	1.04	1.34
Asset Turnover	0.48	0.53	0.48	0.44	0.55
Working Capital Turnover Ratio	-1.44	-1.72	-2.03	-3.83	-34.12
Cash Conversion Cycle	93.82	37.07	157.33	210.41	256.80
Days of Sales Outstanding	61.25	54.93	101.27	107.42	166.03
Days of Inventory Outstanding	231.42	254.87	336.92	371.48	306.75
Days of Payables Outstanding	198.85	272.72	280.86	268.49	215.98
Operating Cycle	292.67	309.79	438.19	478.90	472.78
Cash Flow Ratios
Operating Cash Flow Per Share	0.20	0.26	0.20	0.17	-0.10
Free Cash Flow Per Share	0.17	0.23	0.15	0.11	-0.12
CapEx Per Share	0.03	0.04	0.05	0.06	0.02
Free Cash Flow to Operating Cash Flow	0.85	0.86	0.73	0.64	1.17
Dividend Paid and CapEx Coverage Ratio	6.66	7.02	3.68	2.80	-6.00
Capital Expenditure Coverage Ratio	6.66	7.02	3.68	2.80	-6.00
Operating Cash Flow Coverage Ratio	0.26	0.29	0.19	0.13	-0.07
Operating Cash Flow to Sales Ratio	0.28	0.27	0.20	0.15	-0.06
Free Cash Flow Yield	59.80%	41.04%	16.48%	8.37%	-14.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-4.15	-6.13	-3.31	-4.20	-2.62
Price-to-Sales (P/S) Ratio	0.39	0.57	0.86	1.13	0.48
Price-to-Book (P/B) Ratio	1.12	1.95	2.29	1.96	0.79
Price-to-Free Cash Flow (P/FCF) Ratio	1.67	2.44	6.07	11.94	-6.95
Price-to-Operating Cash Flow Ratio	1.58	2.09	4.42	7.67	-8.11
Price-to-Earnings Growth (PEG) Ratio	-0.30	0.09	0.33	1.30	<0.01
Price-to-Fair Value	1.12	1.95	2.29	1.96	0.79
Enterprise Value Multiple	22.54	32.76	-28.74	-19.45	-19.77
Enterprise Value	461.82M	568.25M	756.24M	901.21M	791.21M
EV to EBITDA	22.54	32.76	-28.74	-19.45	-19.77
EV to Sales	1.37	1.49	1.86	2.01	1.20
EV to Free Cash Flow	5.86	6.37	13.05	21.31	-17.24
EV to Operating Cash Flow	4.98	5.46	9.50	13.69	-20.12
Tangible Book Value Per Share	0.10	0.16	0.25	0.46	0.81
Shareholders’ Equity Per Share	0.28	0.28	0.39	0.65	1.02
Tax and Other Ratios
Effective Tax Rate	-0.02	-0.22	-0.04	>-0.01	-0.04
Revenue Per Share	0.72	0.97	1.03	1.14	1.68
Net Income Per Share	-0.08	-0.09	-0.27	-0.30	-0.31
Tax Burden	1.02	1.23	1.04	1.01	1.04
Interest Burden	2.00	1.58	1.37	1.25	1.30
Research & Development to Revenue	0.04	0.03	0.00	0.05	0.04
SG&A to Revenue	0.59	0.58	0.42	0.35	0.26
Stock-Based Compensation to Revenue	<0.01	<0.01	0.01	<0.01	<0.01
Income Quality	-2.41	-2.93	-0.75	-0.55	0.32

Currency in HKD